dc.contributor.author | Hernandez, Rick | eng |
dc.contributor.author | Edgerton, Lisa | eng |
dc.contributor.author | Flake, Donna | eng |
dc.date.issued | 2008 | eng |
dc.description.abstract | Arthralgias and myalgias have been observed clinically in children and adolescents exposed to fluoroquinolones, but they're transient, disappear when the drug is discontinued, and appear to be no more prevalent than with other antibiotics (strength of recommendation [SOR]: B, 1 structured review and 2 prospective cohort studies). No apparent long-term risk of developmental skeletal growth delay is associated with fluoroquinolone exposure (SOR: B, 1 prospective controlled study). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3792 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2008 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 57, no. 08 (August 2008): 539-540. | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | arthralgia | eng |
dc.subject | skeletal growth | eng |
dc.subject | tendon rupture | eng |
dc.subject | drug resistance | eng |
dc.subject.lcsh | Antibacterial agents -- Side effects | eng |
dc.subject.lcsh | Quinolone antibacterial agents -- Side effects | eng |
dc.subject.lcsh | Infection in children -- Treatment | eng |
dc.title | Is there much risk in using fluoroquinolones in children? | eng |
dc.type | Article | eng |